Advance Tests, a leader in advanced diagnostics, has announced the launch of LucentAD Complete in the United Kingdom, a new and innovative blood test for the early detection of Alzheimer’s Disease. Developed by Lucent Diagnostics, a commercial brand of Quanterix Corporation, this groundbreaking test combines multiple biomarkers to accurately classify the risk of amyloid pathology associated with…
